Joseph Pantginis
Stock Analyst at H.C. Wainwright
Total Price Targets
23
Stocks Covered
12
Sectors
Healthcare
Most Recent
Apr 14, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Joseph Pantginis
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Incorporated | $243.00 | $229.62 | +5.8% | 4 | Apr 14, 2026 |
| PHAR | Pharming Group N.V. | $37.00 | $16.65 | +122.2% | 1 | Mar 12, 2026 |
| LXRX | Lexicon Pharmaceuticals, Inc. | $6.00 | $1.64 | +267.0% | 1 | Mar 12, 2026 |
| CYTK | Cytokinetics, Incorporated | $136.00 | $64.40 | +111.2% | 4 | Dec 22, 2025 |
| XOMA | XOMA Royalty Corp. | $97.00 | $41.23 | +135.2% | 1 | Dec 11, 2025 |
| KURA | Kura Oncology, Inc. | $40.00 | $8.80 | +354.3% | 2 | Nov 14, 2025 |
| NAMS | NewAmsterdam Pharma Company N.V. | $52.00 | $28.65 | +81.5% | 1 | Oct 20, 2025 |
| CAPR | Capricor Therapeutics, Inc. | $24.00 | $31.32 | -23.4% | 2 | Jul 11, 2025 |
| CLDX | Celldex Therapeutics, Inc. | $80.00 | $32.29 | +147.8% | 1 | Oct 29, 2024 |
| BMEA | Biomea Fusion, Inc. | $40.00 | $1.36 | +2830.4% | 3 | Oct 22, 2024 |
| VKTX | Viking Therapeutics, Inc. | $90.00 | $29.80 | +202.0% | 2 | Jun 25, 2024 |
| STTK | Shattuck Labs, Inc. | $16.00 | $7.00 | +128.6% | 1 | Jun 20, 2024 |
Recent Activity
- Apr 14, 2026— Set$243.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Mar 12, 2026— Set$37.00price target onPHAR(Pharming Group N.V.)
- Mar 12, 2026— Set$6.00price target onLXRX(Lexicon Pharmaceuticals, Inc.)
- Feb 24, 2026— Set$239.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Dec 22, 2025— Set$136.00price target onCYTK(Cytokinetics, Incorporated)
- Dec 11, 2025— Set$97.00price target onXOMA(XOMA Royalty Corp.)
- Nov 14, 2025— Set$40.00price target onKURA(Kura Oncology, Inc.)
- Oct 20, 2025— Set$52.00price target onNAMS(NewAmsterdam Pharma Company N.V.)
- Jul 11, 2025— Set$24.00price target onCAPR(Capricor Therapeutics, Inc.)
- Oct 29, 2024— Set$80.00price target onCLDX(Celldex Therapeutics, Inc.)
- Oct 22, 2024— Set$40.00price target onBMEA(Biomea Fusion, Inc.)
- Oct 21, 2024— Set$157.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Oct 17, 2024— Set$120.00price target onCYTK(Cytokinetics, Incorporated)
- Sep 25, 2024— Set$10.00price target onCAPR(Capricor Therapeutics, Inc.)
- Jun 28, 2024— Set$144.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Jun 25, 2024— Set$32.00price target onKURA(Kura Oncology, Inc.)
- Jun 25, 2024— Set$90.00price target onVKTX(Viking Therapeutics, Inc.)
- Jun 20, 2024— Set$16.00price target onSTTK(Shattuck Labs, Inc.)
- Jun 7, 2024— Set$15.00price target onBMEA(Biomea Fusion, Inc.)
- May 23, 2024— Set$90.00price target onCYTK(Cytokinetics, Incorporated)
Frequently Asked Questions
Who is Joseph Pantginis?
Joseph Pantginis is a stock analyst at H.C. Wainwright covering 12 stocks primarily in Healthcare. They have issued 23 price targets since Apr 30, 2022.
What stocks does Joseph Pantginis cover?
Joseph Pantginis currently covers 12 stocks, including LGND, CYTK, BMEA, KURA, CAPR.
What is Joseph Pantginis's latest price target?
Joseph Pantginis's most recent price target was $243.00 on LGND (Ligand Pharmaceuticals Incorporated), set on Apr 14, 2026.
What is Joseph Pantginis's highest price target?
Joseph Pantginis's highest issued price target is $243.00 on LGND, set on Apr 14, 2026.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.